The long axis LV trace calculates...
Cardiology
Quantify cardiac function and structure non-invasively and in real-time!
Your Best Tool For Mouse Echocardiography
Rapid, Repeatable and Well-Established; Ultra High Frequency ultrasound, using the Vevo Imaging Systems, will have an incredible impact on cardiovascular research in your animal models.
Perform reliable echocardiography in mice and other small animals for translational cardiovascular research with in vivo resolution down to 30 microns. Vevo ultrasound imaging platforms provide the best temporal and spatial resolution compared to MRI, conventional ultrasound and CT.
With the Vevo Imaging Systems you can:
- Perform cardiovascular phenotyping for cardiac structure and function
- Image the heart in 4D!
- Quantify diastolic dysfunction
- Evaluate cardiac strain (synchrony and deformation globally or regionally)
- Perform image-guided cardiac injections
- Monitor full animal physiology while imaging: body temperature, ECG and respiratory rate throughout the imaging session.
- Ideal for stress echo and cardiotoxicity studies.
- Assess myocardial oxygen saturation
Mouse left ventricle imaged with 4D Mode from a parasternal long axis view.
Standard mouse echocardiography. Left Ventricular measurements taken from a B-Mode parasternal long axis image.
Mitral flow visualized from an apical view of the mouse left ventricle to assess diastolic function.
B-Mode ultrasound with myocardial oxygen saturation acquired using photoacoustics (PA EKV Mode), from a parasternal long axis view of the mouse left ventricle.
Use Vevo Echocardiography to Image any Cardiac Disease Model, Including:
- Myocardial Infarction
- Cardiotoxicity
- Valvular Disease
- Cardiac Hypertrophy
- Cardiomyopathy
Displaying 1 - 5 of 359 results found
Top Paper
Echocardiographic Strain Analysis for the Early Detection of Left Ventricular Systolic/Diastolic Dysfunction and Dyssynchrony in a Mouse Model of Physiological Aging
Claudio de Lucia, Markus Wallner, Deborah M Eaton, Huaqing Zhao, Steven R Houser, Walter J Koch
The Journals of Gerontology: Series A
.2018
;AT1 receptor blocker inhibits HMGB1 expression in pressure overload-induced acute cardiac dysfunction by suppressing the MAPK/NF-κB signaling pathway
Lei Zhang, Baoli Zhang, Jian Wu, Yunzeng Zou, Hong Jiang, Junbo Ge
Clinical and Experimental Hypertension
.2022
;Mitochondria damage in ambient particulate matter induced cardiotoxicity: Roles of PPAR alpha/PGC-1 alpha signaling
Qixiao Jiang, Andong Ji, Daochuan Li, Limei Shi, Mengyu Gao, Na Lv, Ying Zhang, Rong Zhang, Rui Chen, Wen Chen, Yuxin Zheng, Lianhua Cui
Environmental Pollution
.2021
;Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway
Xue Liu, Weina Han, Na An, Na Cao, Tingting Wu, Shuang Yang, Lili Ding, Xiaoli Chen, Chao Chen, Aruhan Yannan, Zhang Kexin, Wang Lianhuan, Suo Jian, Huang Jinhui, Wang Xin, Zhao Jiuxin, Zhu Yan, Zhang Baofeng, Yang
Frontiers in Pharmacology
.2021
;SH2 domain-containing protein tyrosine phosphatase-2 (SHP-2) prevents cardiac remodeling after myocardial infarction through ERK/SMAD signaling pathway
Yong Gang Lu, He Tan, Qian Ma, Xin Xin Li, Jia Cui, Xue Zhang, Xue Lei Liang, Yan Qing Tie
Human Cell
.2021
;